THE ROLE OF INNOVATIVE TELEMEDICINE TECHNOLOGIES IN DIABETES CARE: A NARRATIVE REVIEW OF METABOLIC, BEHAVIORAL, AND SOCIAL OUTCOMES

Authors

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6172

Keywords:

Diabetes Mellitus, Telemedicine, Telemonitoring, Digital Health, Continuous Glucose Monitoring, Innovative Healthcare Technologies

Abstract

Introduction: Diabetes mellitus remains a major public health challenge worldwide, requiring continuous monitoring, long-term treatment, and active patient participation. Recent advances in telemedicine, continuous glucose monitoring systems, mobile health applications, and artificial intelligence have created new opportunities for remote and personalized diabetes management.

Aim: This narrative review evaluated the impact of telemedicine and digital health technologies on metabolic control, treatment adherence, self-management behaviors, and psychosocial outcomes among adults with type 1 and type 2 diabetes mellitus.

Materials and Methods: A narrative review of the literature was conducted using keywords in the PubMed database. Recent studies involving adult patients with type 1 and type 2 diabetes were analyzed. Attention was paid to outcomes related to glycated hemoglobin (HbA1c), continuous glucose monitoring metrics, treatment adherence, patient engagement, self-management, and quality-of-life indicators.

Results: Most reviewed studies demonstrated that telemedicine interventions significantly improved glycemic control, particularly by reducing HbA1c levels. Digital care models incorporating continuous glucose monitoring increased Time in Range and reduced hyperglycemic exposure. Telemedicine was also associated with improved adherence to treatment recommendations, greater patient engagement, enhanced self-management competencies, and positive psychosocial outcomes, including improved quality of life and reduced diabetes-related distress. The greatest benefits were observed in patients with poor baseline metabolic control and in programs integrating remote monitoring with structured educational support.

Conclusions: Telemedicine represents an effective and innovative complement to conventional diabetes care. Digital health technologies facilitate personalized disease management, improve patient participation in therapeutic processes, and may contribute to more accessible and sustainable healthcare delivery.

References

Bhattacharya, B., Kar, K., Venkatesh, M. P., & Singh, I. (2026). Technology-driven diabetes management: A review of digital therapeutics, mobile apps, and clinical evidence. Informatics for Health and Social Care, 1–21. https://doi.org/10.1080/17538157.2025.2609747

Anthony Jnr, B. (2020). Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic. Journal of Medical Systems, 44(7), 132. https://doi.org/10.1007/s10916-020-01596-5

Chen, L., Chuang, L.-M., Chang, C.-H., Wang, C.-S., Wang, I.-C., Chung, Y., Peng, H.-Y., Chen, H.-C., Hsu, Y.-L., Lin, Y.-S., Chen, H.-J., Chang, T.-C., Jiang, Y.-D., Lee, H.-C., Tan, C.-T., Chang, H.-L., & Lai, F. (2013). Evaluating self-management behaviors of diabetic patients in a telehealthcare program: Longitudinal study over 18 months. Journal of Medical Internet Research, 15(12), e266. https://doi.org/10.2196/jmir.2699

Cogiel, K., Sawina, A., Guzowska, A., Lau, K., & Kasperczyk, J. (2025). Managing chronic disease in the digital era: The role of telemedicine apps and platforms. Przeglad Epidemiologiczny. https://doi.org/10.32394/pe/203948

Cuan, K., Lu, T. X., Goettemoeller, T., Xie, X., Rikin, S., Baron, S. W., Crandall, J. P., & Carruthers, D. J. (2025). Remote patient monitoring with continuous glucose monitoring improves glycemic outcomes in patients with type 2 diabetes at a safety-net hospital. Endocrine Practice. https://doi.org/10.1016/j.eprac.2025.12.016

Cuixart, G., Corcoy, R., & González, C. (2025). Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones, 24(1), 137–147. https://doi.org/10.1007/s42000-024-00609-z

Dario, C., Toffanin, R., Calcaterra, F., Saccavini, C., Stafylas, P., Mancin, S., & Vio, E. (2017). Telemonitoring of type 2 diabetes mellitus in Italy. Telemedicine and E-Health, 23(2), 143–152. https://doi.org/10.1089/tmj.2015.0224

Davidson, M. B., & Davidson, S. J. (2019). Effect of remote glucose monitoring utilizing computerized insulin dose adjustment algorithms: A pilot project. Diabetes Therapy, 10(2), 523–533. https://doi.org/10.1007/s13300-019-0565-y

De Groot, J., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021). Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World Journal of Diabetes, 12(2), 170–197. https://doi.org/10.4239/wjd.v12.i2.170

Dicembrini, I., Poggi, C. D., Del Vescovo, G. G., Marinelli, C., Scoccimarro, D., Vitale, V., Silverii, G. A., Drigani, L., Pancani, F., Norgiolini, R., Di Cianni, G., & Mannucci, E. (2026). Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal-bolus insulin therapy: A randomised controlled trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70511

Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020). A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits. Journal of Diabetes Science and Technology, 14(5), 908–911. https://doi.org/10.1177/1932296819888662

Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017). Effect of telemedicine on glycated hemoglobin in diabetes: A systematic review and meta-analysis of randomized trials. Canadian Medical Association Journal, 189(9), E341–E364. https://doi.org/10.1503/cmaj.150885

Fritzen, K., Basinska, K., Rubio-Almanza, M., Nicolucci, A., Kennon, B., Vergès, B., Zakrzewska, K., & Schnell, O. (2019). Pan-European economic analysis to identify cost savings for the health care systems as a result of integrating glucose monitoring based telemedical approaches into diabetes management. Journal of Diabetes Science and Technology, 13(6), 1112–1122. https://doi.org/10.1177/1932296819835172

Gaudillère, M., Pollin-Javon, C., Brunot, S., Villar Fimbel, S., & Thivolet, C. (2021). Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme. Diabetes & Metabolism, 47(6), 101251. https://doi.org/10.1016/j.diabet.2021.101251

Gómez Medina, A. M., Henao Carrillo, D. C., Silva León, J. D., Gómez González, J. A., Muñoz Velandia, O. M., Conde Brahim, L., Mecón Prada, G. A., & Rondón Sepúlveda, M. (2025). Results from a virtual clinic for the follow-up of patients using the advanced hybrid closed-loop system. Journal of Diabetes Science and Technology, 19(3), 778–786. https://doi.org/10.1177/19322968231204376

González-Molero, I., Domínguez-López, M., Guerrero, M., Carreira, M., Caballero, F., Rubio-Martín, E., Linares, F., Cardona, I., Anarte, M. T., De Adana, M. S. R., & Soriguer, F. (2012). Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring. Journal of Telemedicine and Telecare, 18(6), 328–332. https://doi.org/10.1258/jtt.2012.120103

Guzman, G. E., Escobar, M. F., Arias-Valderrama, O., Guerra, M. A., & Martínez, V. (2023). Clinical experience of using telemedicine for the management of patients using continuous subcutaneous insulin infusion in a highly complex Latin American hospital. International Journal of Environmental Research and Public Health, 20(9), 5719. https://doi.org/10.3390/ijerph20095719

Hangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023). The effectiveness of telemedicine solutions for the management of type 2 diabetes: A systematic review, meta-analysis, and meta-regression. Journal of Diabetes Science and Technology, 17(3), 794–825. https://doi.org/10.1177/19322968211064633

Hood, K., Bergenstal, R. M., Cushman, T., Gal, R. L., Raghinaru, D., Kruger, D., Johnson, M. L., McArthur, T., Bradshaw, A., Olson, B. A., Oser, S. M., Oser, T. K., Kollman, C., Weinstock, R. S., Beck, R. W., & Aleppo, G. (2024). Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. Telemedicine and E-Health. https://doi.org/10.1089/tmj.2024.0093

Jeong, J. Y., Jeon, J.-H., Bae, K.-H., Choi, Y.-K., Park, K.-G., Kim, J.-G., Won, K. C., Cha, B. S., Ahn, C. W., Kim, D. W., Lee, C. H., & Lee, I.-K. (2018). Smart care based on telemonitoring and telemedicine for type 2 diabetes care: Multi-center randomized controlled trial. Telemedicine and E-Health, 24(8), 604–613. https://doi.org/10.1089/tmj.2017.0203

Lau, D., Manca, D. P., Singh, P., Perry, T., Olu-Jordan, I., Ryan Zhang, J., Rahim, G., Hagen, E. M., & Yeung, R. O. (2024). The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial. Diabetes Research and Clinical Practice, 217, 111899. https://doi.org/10.1016/j.diabres.2024.111899

Lee, P. A., Greenfield, G., & Pappas, Y. (2018). The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: A systematic review and meta-analysis of systematic reviews of randomised controlled trials. BMC Health Services Research, 18(1), 495. https://doi.org/10.1186/s12913-018-3274-8

Majithia, A. R., Kusiak, C. M., Armento Lee, A., Colangelo, F. R., Romanelli, R. J., Robertson, S., Miller, D. P., Erani, D. M., Layne, J. E., Dixon, R. F., & Zisser, H. (2020). Glycemic outcomes in adults with type 2 diabetes participating in a continuous glucose monitor–driven virtual diabetes clinic: Prospective trial. Journal of Medical Internet Research, 22(8), e21778. https://doi.org/10.2196/21778

Michaud, T. L., Siahpush, M., Estabrooks, P., Schwab, R. J., LeVan, T. D., Grimm, B., Ramos, A. K., Johansson, P., Scoggins, D., & Su, D. (2020). Association between weight loss and glycemic outcomes: A post hoc analysis of a remote patient monitoring program for diabetes management. Telemedicine and E-Health, 26(5), 621–628. https://doi.org/10.1089/tmj.2019.0030

Montero, A. R., Toro-Tobon, D., Gann, K., Nassar, C. M., Youssef, G. A., & Magee, M. F. (2021). Implications of remote monitoring technology in optimizing traditional self-monitoring of blood glucose in adults with T2DM in primary care. BMC Endocrine Disorders, 21(1). https://doi.org/10.1186/s12902-021-00884-6

Mubeen, F., Low Wang, C. C., Al Maradni, A., Shivaswamy, V., & Sadhu, A. R. (2023). Digital health and shared decision-making in diabetes care—A survey initiative in patients and clinicians. Endocrine Practice, 29(7), 538–545. https://doi.org/10.1016/j.eprac.2023.04.012

Nieto De La Marca, M. D. L. O., Díaz-Soto, G., Sánchez Ibáñez, M., Del Amo Simón, S., Fernández Velasco, P., Torres Torres, B., López Gómez, J. J., Gómez Hoyos, E., Ortolá Buigues, A., Delgado García, E., & De Luis Román, D. (2023). Metabolic control and satisfaction in a diabetes education programme in flash glucose monitoring through telemedicine in type 1 diabetes. Endocrinología, Diabetes y Nutrición (English Ed.), 70(6), 408–414. https://doi.org/10.1016/j.endien.2022.01.009

Notemi, L. M., Amoura, L., Fall Mostaine, F., Meyer, L., Paris, D., Talha, S., Pottecher, J., & Kessler, L. (2022). Long-term efficacy of sensor-augmented pump therapy (Minimed 640G system) combined with a telemedicine follow-up in patients with type 1 diabetes: A real life study. Journal of Clinical & Translational Endocrinology, 30, 100306. https://doi.org/10.1016/j.jcte.2022.100306

Ólafsdóttir, A. F., Sveen, K.-A., Wijkman, M., Hallström, S., Nilsson, P.-H., Sterner Isaksson, S., Holmer, H., Ekström, M., Imberg, H., & Lind, M. (2025). Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: A multicentre, open-label, randomised controlled trial. The Lancet Regional Health – Europe, 59, 101485. https://doi.org/10.1016/j.lanepe.2025.101485

Pyatak, E. A., Lee, P.-J., Nnoli, N. D., Mo, Y., Khurana, A., Ali, A., Fox, D. S., Sideris, J., Diaz, J., Granados, G., Blanchard, J., Lee, E. S., & Raymond, J. K. (2025). Telehealth occupational therapy improves psychosocial well-being but not glycemia among young adults with type 1 diabetes: The Resilient, Empowered, Active Living-Telehealth (REAL-T) randomized controlled trial. Diabetes Research and Clinical Practice, 221, 112005. https://doi.org/10.1016/j.diabres.2025.112005

Rigla, M., Hernando, M. E., Gómez, E. J., Brugués, E., García-Sáez, G., Capel, I., Pons, B., & De Leiva, A. (2008). Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients. Diabetes Technology & Therapeutics, 10(3), 194–199. https://doi.org/10.1089/dia.2007.0273

Rodríguez De Vera-Gómez, P., Mateo-Rodríguez, C., Vivas-López, C., Serrano-Olmedo, I., Méndez-Muros, M., Morales-Portillo, C., Sevillano Jiménez, M., Hernández-Herrero, C., & Martínez-Brocca, M. A. (2022). Effectiveness of a flash glucose monitoring systems implementation program through a group and telematic educational intervention in adults with type 1 diabetes. Endocrinología, Diabetes y Nutrición (English Ed.), 69(9), 657–668. https://doi.org/10.1016/j.endien.2022.11.002

Saetang, T., Greeviroj, P., Thavaraputta, S., Santisitthanon, P., Houngngam, N., & Laichuthai, N. (2024). The effectiveness of telemonitoring and integrated personalized diabetes management in people with insulin-treated type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 26(11), 5233–5238. https://doi.org/10.1111/dom.15870

Salzsieder, E., Augstein, P., Vogt, L., Kohnert, K.-D., Heinke, P., Freyse, E.-J., Ahmed, A. A., Metwali, Z., Salman, I., & Attef, O. (2007). Telemedicine-based KADIS® combined with CGMS™ has high potential for improving outpatient diabetes care. Journal of Diabetes Science and Technology, 1(4), 511–521. https://doi.org/10.1177/193229680700100409

Schultz, A. N. Ø., Christensen, R., Bollig, G., Kidholm, K., & Brandt, F. (2026). Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: A randomised controlled trial. Diabetologia, 69(2), 321–329. https://doi.org/10.1007/s00125-025-06585-2

Su, D., Michaud, T. L., Estabrooks, P., Schwab, R. J., Eiland, L. A., Hansen, G., DeVany, M., Zhang, D., Li, Y., Pagán, J. A., & Siahpush, M. (2019). Diabetes management through remote patient monitoring: The importance of patient activation and engagement with the technology. Telemedicine and E-Health, 25(10), 952–959. https://doi.org/10.1089/tmj.2018.0205

Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019). Clinical effectiveness of telemedicine in diabetes mellitus: A meta-analysis of 42 randomized controlled trials. Telemedicine and E-Health, 25(7), 569–583. https://doi.org/10.1089/tmj.2018.0128

Toschi, E., Adam, A., Frimpong, N., Hurlbert, R., Slyne, C., Laffel, L., & Munshi, M. (2024). Hybrid care model: Combining telemedicine and office visits for diabetes management in older adults with type 1 diabetes. Medical Research Archives, 12(9), 5728. https://doi.org/10.18103/mra.v12i9.5728

Turnin, M.-C., Gourdy, P., Martini, J., Buisson, J.-C., Chauchard, M.-C., Delaunay, J., Schirr-Bonnans, S., Taoui, S., Poncet, M.-F., Cosma, V., Lablanche, S., Coustols-Valat, M., Chaillous, L., Thivolet, C., Sanz, C., Penfornis, A., Lepage, B., Colineaux, H., Mounié, M., . . . Educ@dom Study Group. (2021). Impact of a remote monitoring programme including lifestyle education software in type 2 diabetes: Results of the Educ@dom randomised multicentre study. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders, 12(7), 2059–2075. https://doi.org/10.1007/s13300-021-01095-x

Vitale, R. J., Pillai, P. B., Krishnan, G., Jothydev, S., & Kesavadev, J. (2016). The two levels of care for diabetes in a developing country: Mechanisms for improved intermediate health outcomes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10(1), S90–S94. https://doi.org/10.1016/j.dsx.2015.09.025

Wang, G., Zhang, Z., Feng, Y., Sun, L., Xiao, X., Wang, G., Gao, Y., Wang, H., Zhang, H., Deng, Y., & Sun, C. (2017). Telemedicine in the management of type 2 diabetes mellitus. The American Journal of the Medical Sciences, 353(1), 1–5. https://doi.org/10.1016/j.amjms.2016.10.008

Weinstock, R. S., Raghinaru, D., Gal, R. L., Bergenstal, R. M., Bradshaw, A., Cushman, T., Kollman, C., Kruger, D., Johnson, M. L., McArthur, T., Olson, B. A., Oser, S. M., Oser, T. K., Beck, R. W., Hood, K., & Aleppo, G. (2024). Older adults benefit from virtual support for continuous glucose monitor use but require longer visits. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968241294250

Williamson, R. J., Powell, R., & Shepherd, A. K. (2024). Improving diabetic care through education and innovation. Journal of Doctoral Nursing Practice, 17(2), 86–99. https://doi.org/10.1891/jdnp-2023-0060

Zakaria, H., Said, Y., Aleabova, S., Bangayan, J., Dandan, M., Debs, J., Dahlstrom, N., Divino, D., Hashemi, A., & Almarzooqi, I. (2024). Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1355792

Downloads

Published

2026-08-06

How to Cite

Wojtera, A., Urantówka, N., Węglarz, A. K., Borowiecka, P. A., Adamarczuk, J. A., Głuski, J., Miciak, A. A., Kaszowska, K. B., Dąbrowski, T. P., Kaczmarz-Chojnacka, K., & Buziak, J. (2026). THE ROLE OF INNOVATIVE TELEMEDICINE TECHNOLOGIES IN DIABETES CARE: A NARRATIVE REVIEW OF METABOLIC, BEHAVIORAL, AND SOCIAL OUTCOMES. International Journal of Innovative Technologies in Social Science, 1(3(51). https://doi.org/10.31435/ijitss.3(51).2026.6172

Most read articles by the same author(s)